Related references
Note: Only part of the references are listed.Association of diabetes and diabetes treatment with incidence of breast cancer
Esther Garcia-Esquinas et al.
ACTA DIABETOLOGICA (2016)
The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
Pauline A. J. Vissers et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
ROS-Mediated DNA Methylation Pattern Alterations in Carcinogenesis
Qihan Wu et al.
CURRENT DRUG TARGETS (2015)
The role of the insulin-like growth factor-1 system in breast cancer
Panagiotis F. Christopoulos et al.
MOLECULAR CANCER (2015)
Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance
Ashfaque A. Memon et al.
JOURNAL OF DIABETES (2015)
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Hee Jeong Kim et al.
BREAST CANCER RESEARCH (2015)
Oxidative stress in susceptibility to breast cancer: study in Spanish population
Patricia Rodrigues et al.
BMC CANCER (2014)
Impact of Tumor Removal on the Systemic Oxidative Profile of Patients With Breast Cancer Discloses Lipid Peroxidation at Diagnosis as a Putative Marker of Disease Recurrence
Ana Cristina S. Herrera et al.
CLINICAL BREAST CANCER (2014)
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus
G. E. C. Sun et al.
DIABETES OBESITY & METABOLISM (2014)
Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties
Mona M. Mohamed et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study
H. C. Lin et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Stress Biology and Aging Mechanisms: Toward Understanding the Deep Connection Between Adaptation to Stress and Longevity
Elissa S. Epel et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
Eveline A. I. F. Queiroz et al.
PLOS ONE (2014)
Tumor Microenvironment and Metabolic Synergy in Breast Cancers: Critical Importance of Mitochondrial Fuels and Function
Ubaldo Martinez-Outschoorn et al.
SEMINARS IN ONCOLOGY (2014)
Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer
Yuanting Xiao et al.
TUMOR BIOLOGY (2014)
The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
Bridget A. Oppong et al.
CANCER MEDICINE (2014)
Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked
Rosalina Wisastra et al.
CANCERS (2014)
Diabetes and cancer: Associations, mechanisms, and implications for medical practice
Chun-Xiao Xu et al.
WORLD JOURNAL OF DIABETES (2014)
IGF binding proteins in cancer: mechanistic and clinical insights
Robert C. Baxter
NATURE REVIEWS CANCER (2014)
Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression
Candace A. Gilbert et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Redox Molecular Machines Involved in Tumor Progression
Matteo Parri et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Insulin-like growth factor - Oestradiol crosstalk and mammary gland tumourigenesis
Yousef Hawsawi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
Guofang Hou et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
K. M. J. de Bruijn et al.
BRITISH JOURNAL OF SURGERY (2013)
Association of metformin use with cancer incidence and mortality: A meta-analysis
Pengpeng Zhang et al.
CANCER EPIDEMIOLOGY (2013)
The Links Between Insulin Resistance, Diabetes, and Cancer
Etan Orgel et al.
CURRENT DIABETES REPORTS (2013)
Association Between Metformin Therapy and Mortality After Breast Cancer A population-based study
Iliana C. Lega et al.
DIABETES CARE (2013)
DIABETES AND CANCER-AN AACE/ACE CONSENSUS STATEMENT
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2013)
High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease
Pamela Minicozzi et al.
EUROPEAN JOURNAL OF CANCER (2013)
Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
Morihiro Matsuda et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Emily J. Gallagher et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2013)
Latest insights into the risk of cancer in diabetes
Hiroshi Noto et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Prognostic Role of Interleukin-6, Interleukin-8, and Leptin Levels According to Breast Cancer Subtype
Young Ae Cho et al.
CANCER RESEARCH AND TREATMENT (2013)
Use of Metformin and Survival of Diabetic Women with Breast Cancer
Paul J. H. L. Peeters et al.
CURRENT DRUG SAFETY (2013)
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+breast cancer
X. He et al.
ANNALS OF ONCOLOGY (2012)
Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities
Patrizia Ferroni et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Analysis of AGE modified proteins and RAGE expression in HER2/neu negative invasive ductal carcinoma
Arvind M. Korwar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
C. Panis et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metformin and breast cancer risk: a meta-analysis and critical literature review
Nananda F. Col et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
Soley Bayraktar et al.
CANCER (2012)
Diabetes and cancer I: risk, survival, and implications for screening
Adedayo A. Onitilo et al.
CANCER CAUSES & CONTROL (2012)
Obesity-Driven Inflammation and Colorectal Cancer
N. Vazzana et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
I. N. Colmers et al.
DIABETES & METABOLISM (2012)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Mortality After Incident Cancer in People With and Without Type 2 Diabetes Impact of metformin on survival
Craig J. Currie et al.
DIABETES CARE (2012)
Insulinemia and the risk of breast cancer and its relapse
V. Formica et al.
DIABETES OBESITY & METABOLISM (2012)
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
T. P. van Staa et al.
DIABETOLOGIA (2012)
The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression
David P. Rose et al.
ENDOCRINE-RELATED CANCER (2012)
Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms
Biagio Arcidiacono et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer
Michael Weichhaus et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia
Wei-Wu Chen et al.
ONCOLOGIST (2012)
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna et al.
ONCOLOGIST (2012)
Interplay Between Insulin Resistance and Estrogen Deficiency as co- Activators in Carcinogenesis
Zsuzsanna Suba
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Meta-analysis confirms raised risk of bladder cancer from pioglitazone
Barbara Kermode-Scott
BRITISH MEDICAL JOURNAL (2012)
Systematic Review and Meta-analysis of Insulin Therapy and Risk of Cancer
Mohsen Janghorbani et al.
HORMONES & CANCER (2012)
Type 2 Diabetes and Obesity Metabolic Interactions: Common Factors for Breast Cancer Risk and Novel Approaches to Prevention and Therapy
Linda Vona-Davis et al.
CURRENT DIABETES REVIEWS (2012)
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
NATURE REVIEWS CANCER (2012)
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Lev M. Berstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Diabetes and prognosis in a breast cancer cohort
Michael G. Schrauder et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Kimberly S. Peairs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms
Gabriel Chodick et al.
WOMENS HEALTH (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Ian F. Godsland
CLINICAL SCIENCE (2010)
Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics
Jodi E. Goldberg et al.
CURRENT DRUG TARGETS (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss
Jose Manuel Fernandez-Real et al.
NUTRITION & METABOLISM (2010)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Obesity and Breast Cancer: The Estrogen Connection
Margot P. Cleary et al.
ENDOCRINOLOGY (2009)
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
Milena Sant et al.
EUROPEAN JOURNAL OF CANCER (2009)
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer
Geoffrey C. Kabat et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
IGF-I plus E2 induces proliferation via activation of ROS-Dependent ERKs and JNKs in human breast carcinoma cells
Cheng-Wei Lin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
IGF1R signalling and its inhibition
J. Riedemann et al.
ENDOCRINE-RELATED CANCER (2006)
Aromatase and the breast: Regulation and clinical aspects
W. R. Miller
MATURITAS (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Hyperinsulinaemia and increased risk of breast cancer: findings from the British women's heart and health study
DA Lawlor et al.
CANCER CAUSES & CONTROL (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Oxidative DNA damage by hyperglycemia-related aldehydes and its marked enhancement by hydrogen peroxide
M Murata et al.
FEBS LETTERS (2003)
Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis
ZY Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland
AV Lee et al.
ENDOCRINOLOGY (2003)
Plasma malondialdehyde (MDA) levels in breast and lung cancer patients
A Gönenç et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2001)
Share Paper
